Published online before print August 1, 2005, doi: 10.1161/CIRCULATIONAHA.104.506337
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:900-905.)
© 2005 American Heart Association, Inc.
Stroke |
C-Reactive Protein and Cerebral Small-Vessel Disease
The Rotterdam Scan Study
From the Department of Epidemiology & Biostatistics (E.J.v.D., N.D.P., S.E.V., A.H., M.M.B.B.), Department of Neurology (E.J.v.D., N.D.P., S.E.V., P.J.K.), and Department of Medical Informatics and Department of Radiology (H.A.V.), Erasmus Medical Center, Rotterdam, the Netherlands.
Correspondence to M.M.B. Breteler, MD, PhD, Department of Epidemiology & Biostatistics, Erasmus Medical Center, PO Box 1738, 3000DR Rotterdam, The Netherlands. E-mail m.breteler{at}erasmusmc.nl
Received September 11, 2004; revision received March 17, 2005; accepted April 12, 2005.
Background— Inflammatory processes are involved in the development and consequences of atherosclerosis. Whether these processes are also involved in cerebral small-vessel disease is unknown. Cerebral white matter lesions and lacunar brain infarcts are caused by small-vessel disease and are commonly observed on MRI scans in elderly people. These lesions are associated with an increased risk of stroke and dementia. We assessed whether higher C-reactive protein (CRP) levels were related to white matter lesion and lacunar infarcts.
Methods and Results— We based our study on 1033 participants of the population-based Rotterdam Scan Study for whom complete data on CRP levels were available and who underwent brain MRI scanning. Subjects were 60 to 90 years of age and free of dementia at baseline. Six hundred thirty-six subjects had a second MRI scan on average 3.3 years later. We used multivariate regression models to assess the associations between CRP levels and markers of small-vessel disease. Higher CRP levels were associated with presence and progression of white matter lesions, particularly with marked lesion progression (ORs for highest versus lowest quartile of CRP 3.1 [95% CI 1.3 to 7.2] and 2.5 [95% CI 1.1 to 5.6] for periventricular and subcortical white matter lesion progression, respectively). These associations persisted after adjustment for cardiovascular risk factors and carotid atherosclerosis. Persons with higher CRP levels tended to have more prevalent and incident lacunar infarcts.
Conclusions— Inflammatory processes may be involved in the pathogenesis of cerebral small-vessel disease, in particular, the development of white matter lesions.
Key Words: inflammation • magnetic resonance imaging • cerebral infarction • microcirculation • cerebral ischemia
Related Article:
Circulation 2005 112: 781-785.
This article has been cited by other articles:
 |
|
 |
|
  C. S. Thompson and A. M. Hakim Living Beyond Our Physiological Means: Small Vessel Disease of the Brain Is an Expression of a Systemic Failure in Arteriolar Function: A Unifying Hypothesis Stroke, May 1, 2009; 40(5): e322 - e330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Baune, G. Ponath, M. Rothermundt, A. Roesler, and K. Berger Association Between Cytokines and Cerebral MRI Changes in the Aging Brain J Geriatr Psychiatry Neurol, March 1, 2009; 22(1): 23 - 34. [Abstract] [PDF]
|
|
|
|
|
|
B. T. Baune The Puzzle of Predicting the Impact of Brain Infarcts on Cognitive Impairment in the Aging Brain Stroke, March 1, 2009; 40(3): 667 - 669. [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. J. Strachan, R. M. Reynolds, B. M. Frier, R. J. Mitchell, and J. F. Price The relationship between type 2 diabetes and dementia Br. Med. Bull., December 1, 2008; 88(1): 131 - 146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Silbert, C. Nelson, D. B. Howieson, M. M. Moore, and J. A. Kaye Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline Neurology, July 8, 2008; 71(2): 108 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M van Oijen, E Y L Cheung, C E M Geluk, A Hofman, P J Koudstaal, M M B Breteler, and M P de Maat Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study J. Neurol. Neurosurg. Psychiatry, July 1, 2008; 79(7): 799 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fornage, Y. A. Chiang, E. S. O'Meara, B. M. Psaty, A. P. Reiner, D. S. Siscovick, R. P. Tracy, and W.T. Longstreth Jr Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study Stroke, July 1, 2008; 39(7): 1952 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Galluzzi, C. Geroldi, L. Benussi, R. Ghidoni, C. Testa, G. Borsci, M. Bonetti, D. Manfellotto, G. Romanelli, R. Zulli, et al. Association of Blood Pressure and Genetic Background With White Matter Lesions in Patients With Mild Cognitive Impairment J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2008; 63(5): 510 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Ikram, M. W. Vernooij, A. Hofman, W. J. Niessen, A. van der Lugt, and M. M.B. Breteler Kidney Function Is Related to Cerebral Small Vessel Disease Stroke, January 1, 2008; 39(1): 55 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schmidt, K. Petrovic, S. Ropele, C. Enzinger, and F. Fazekas Progression of Leukoaraiosis and Cognition Stroke, September 1, 2007; 38(9): 2619 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Reitz, K. Berger, M. P.M. de Maat, M. Stoll, F. Friedrichs, I. Kardys, J. C.M. Witteman, and M. M.B. Breteler CRP Gene Haplotypes, Serum CRP, and Cerebral Small-Vessel Disease: The Rotterdam Scan Study and the MEMO Study Stroke, August 1, 2007; 38(8): 2356 - 2359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Ridker C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2129 - 2138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Jefferson, J. M. Massaro, P. A. Wolf, S. Seshadri, R. Au, R. S. Vasan, M. G. Larson, J. B. Meigs, J. F. Keaney Jr, I. Lipinska, et al. Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study Neurology, March 27, 2007; 68(13): 1032 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ishikawa, Y. Tamura, S. Hoshide, K. Eguchi, S. Ishikawa, K. Shimada, and K. Kario Low-Grade Inflammation Is a Risk Factor for Clinical Stroke Events in Addition to Silent Cerebral Infarcts in Japanese Older Hypertensives: The Jichi Medical School ABPM Study, Wave 1 Stroke, March 1, 2007; 38(3): 911 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schmidt, H. Schmidt, M. Pichler, C. Enzinger, K. Petrovic, K. Niederkorn, S. Horner, S. Ropele, N. Watzinger, M. Schumacher, et al. C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel Disease: Results of the Austrian Stroke Prevention Study Stroke, December 1, 2006; 37(12): 2910 - 2916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. van Harten, F.-E. de Leeuw, H. C. Weinstein, P. Scheltens, and G. J. Biessels Brain Imaging in Patients With Diabetes: A systematic review. Diabetes Care, November 1, 2006; 29(11): 2539 - 2548. [Full Text] [PDF]
|
|
|
|
|
|
P. Libby and P. M. Ridker Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical Practice J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A33 - A46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Dziedzic Systemic inflammatory markers and risk of dementia. American Journal of Alzheimer's Disease and Other Dementias, August 1, 2006; 21(4): 258 - 262. [Abstract] [PDF]
|
|
|
|
|
|
Y. W. Chen, M. E. Gurol, J. Rosand, A. Viswanathan, S. M. Rakich, T. R. Groover, S. M. Greenberg, and E. E. Smith Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology, July 11, 2006; 67(1): 83 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Tanne, M. Benderly, U. Goldbourt, M. Haim, A. Tenenbaum, E. Z. Fisman, Z. Matas, Y. Adler, R. Zimmlichman, and S. Behar C-Reactive Protein as a Predictor of Incident Ischemic Stroke Among Patients With Preexisting Cardiovascular Disease Stroke, July 1, 2006; 37(7): 1720 - 1724. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Aboyans, M. H. Criqui, J. O. Denenberg, J. D. Knoke, P. M Ridker, and A. Fronek Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels Circulation, June 6, 2006; 113(22): 2623 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Hogue Jr, T. Hershey, D. Dixon, R. Fucetola, A. Nassief, K. E. Freedland, B. Thomas, and K. Schechtman Preexisting cognitive impairment in women before cardiac surgery and its relationship with C-reactive protein concentrations. Anesth. Analg., June 1, 2006; 102(6): 1602 - 1608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Pijak Rebound Inflammation and the Risk of Ischemic Stroke After Discontinuation of Aspirin Therapy Arch Neurol, February 1, 2006; 63(2): 300 - 301. [Full Text] [PDF]
|
|
|
|
|
|
A. Chamorro and J. Hallenbeck The Harms and Benefits of Inflammatory and Immune Responses in Vascular Disease Stroke, February 1, 2006; 37(2): 291 - 293. [Full Text] [PDF]
|
|
|
|
|
|
M. D. Napoli and F. Papa C-Reactive Protein and Cerebral Small-Vessel Disease: An Opportunity to Reassess Small-Vessel Disease Physiopathology? Circulation, August 9, 2005; 112(6): 781 - 785. [Full Text] [PDF]
|
|